Description
COMPOSITION : Each Hard Gelatin Capsules
contains: Sunitinib Malate 12.5mg/25mg/50mg
SUTEKAST is indicated for treatment of
Gastrointestinal Stromal Tumor (GIST) after
disease progression on or intolerance to imatinib
mesylate.
Sutekast is indicated for the treamtment of
pancreatic cancer known as pancreatic neuroendocrine
tumors (PNETs) that has progressed and cannot be treated
with surgery or metastatic disease
SUTEKAST is also indicated for the treatment of
aadvanced kidney carcinoma.
PACKING: 28 Capsules / Bottle
